Sale!
IGF-LR3 Canada 1mg vial2 LAB COAsFresh COA · Aug 11, 2026
IGF-LR3 Canada 1mg COA
IGF-LR3 Canada – Laboratory Research Reagent (1mg) - Image 3
IGF-LR3 Canada – Laboratory Research Reagent (1mg) - Image 4
Independent Batch Testing
Janoshik and Kovera Labs reports are available for this batch.

IGF-LR3 Canada – Laboratory Research Reagent (1mg)

Original price was: $75.00.Current price is: $70.00.

IGF-LR3 Canada is supplied as 1mg lyophilized material in a 3 mL glass vial. Ships from Ontario, Canada.
For non-clinical laboratory research use only — not for human or animal consumption.

In stock

Same-batch planning Many research customers order multiple vials from the same batch.
SKU: NRX-IGFLR3-1 Category: Tags: , , , , , , , ,

Batch Verification

Batch: 2511-2-264
This batch has been independently tested through Janoshik and Kovera Labs.
Janoshik Janoshik
Purity + mass verification
Avg. Purity
96.216%
Avg. Mass
1.15 mg
Result Date
May 11, 2026
Janoshik report batch: 2511-2-264
Measured purity + mass on the Janoshik report.
View Janoshik Report
Kovera Labs
Identity + safety screen verification
Purity
99.528%
Net Content
1.01 mg
Identity
Confirmed
Endotoxin
Pass
Heavy Metals
Pass
Rapid Sterility
Pass
14-Day Sterility
Pass
Report Date
Aug 11, 2026
Kovera report batch: 2511-2-264
View Kovera Report

Description

IGF-LR3 Canada (1mg) – Laboratory Research Reagent

igf-lr3 canada is supplied as lyophilized material for non-clinical laboratory research by qualified facilities and trained personnel.

Product details

  • Net content: 1 mg per vial
  • Format: Lyophilized material
  • Container: 3 mL glass vial
  • Lot/batch: Recorded on product label where available

Intended use

  • Non-clinical laboratory research
  • Analytical reference and assay development within institutional programs
  • Use only in accordance with institutional SOPs and applicable regulatory requirements
  • Not for human or animal consumption
  • Not for clinical, therapeutic, or diagnostic use

Research documentation

This page consolidates the identified batch number, reported laboratory measurements, result dates and direct report links for the currently listed material. Each result applies only to the identified batch and should be reviewed together with the original laboratory report.

Laboratory recordkeeping

Qualified facilities should document receipt date, product identity, batch number, label condition, chain of custody and final disposition under their institutional SOPs. Analytical interpretation should account for the laboratory method, reported measurement and scope of each report. Product-page summaries do not replace the source documentation.

Upon receipt, laboratories should inspect the vial and label, retain the supplied batch identifier, and link all internal records to the applicable source report. Storage, handling, sampling, assay conditions, deviations and disposition should follow the facility’s validated procedures and the product label.

Certificate of Analysis (COA)

The second and fourth product images show the Janoshik and Kovera Certificates of Analysis for IGF-LR3 Canada 1mg, respectively.

Batch-specific verification for IGF-LR3 Canada 1mg is available above through the linked Janoshik and Kovera Labs reports, including purity, mass/net content, identity, endotoxin, heavy metals, rapid sterility, and 14-day sterility reported for batch 2511-2-264.

Shipping

  • Ships from Ontario, Canada
  • Availability is shown on this page

For additional options, view our full range of research products available in Canada.

Additional information

Weight 5 g
Dimensions 1.6 × 1.6 × 4 cm

Related products